Nucleai

Chicago, United States

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

$14.0M raised

Apr 2024

Venture - Series Unknown

Top Investors

S32Vertex Ventures IsraelFosun RZ CapitalGrove VenturesM Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nucleai raised?

Nucleai has raised $14.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.

Who are Nucleai's investors?

Nucleai's investors include S32, Vertex Ventures Israel, Fosun RZ Capital, Grove Ventures, M Ventures.

Where is Nucleai headquartered?

Nucleai is headquartered in Chicago, United States.

What does Nucleai do?

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

What stage is Nucleai at?

Nucleai is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 3, 2024.

MLA

"Nucleai — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/nucleai. Accessed June 3, 2026.

APA

VCBacked. (2024). Nucleai — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/nucleai

Wikipedia (cite web)

{{cite web |title=Nucleai — Funding & Investors |url=https://www.vcbacked.co/company/nucleai |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 3, 2024.